Key Players
Competitive Landscape
Four supplier models compete in the continuous bioprocessing market: global platform groups and process-intensification specialists alongside automation integrators and integrated manufacturing service providers.
Capital has shifted since 2025 toward process analytics and expanded downstream purification portfolios across regulated manufacturing. In March 2025, Repligen purchased four desktop PAT devices from 908 Devices for USD 70 million. In April 2026, MilliporeSigma completed its acquisition of JSR Life Sciences' chromatography business for antibody purification. Price remains relevant but manufacturers first compare integration depth, qualification evidence and regional technical support.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| Repligen purchased four desktop PAT devices from 908 Devices for USD 70 million in March 2025. | Manufacturers require real-time measurements to control long connected runs without waiting for offline laboratory results. | Process analytics are becoming part of equipment architecture instead of remaining a separate instrument layer. | Integrated sensor packages support revenue from filtration control and process scale-up across connected manufacturing operations. |
| MilliporeSigma completed the JSR Life Sciences chromatography acquisition in April 2026 and added Amsphere Protein A resins. | Antibody manufacturers need dependable capture capacity as upstream titers increase across commercial production campaign sites. | Downstream portfolios increasingly combine chromatography resins with filtration and application support across connected purification workflows. | Protein A workflows provide revenue across continuous and intensified antibody purification operations requiring dependable capture performance. |
| Thermo Fisher opened Hyderabad and expanded Incheon and Singapore design centers in December 2025 for regional bioprocess support. | Asian manufacturers need nearby engineering support for process design and scale-up across single-use production sites. | Global platform groups are placing application centers closer to concentrated biologics production regions across Asia. | Regional engineering and training services earn revenue by supporting qualification of single-use production platforms across Asian sites. |
Eppendorf and Getinge compete through upstream development systems and life-science process support, with no dated continuous-bioprocessing developments recorded during this period.
Source: Future Market Insights, Continuous Bioprocessing Market and Bioprocessing Systems Market Reports, 2026-2036.
Cytiva, Sartorius, Thermo Fisher Scientific, Merck and Repligen collectively cover perfusion, purification, single-use hardware, process analytics and connected control.
Who leads the continuous bioprocessing market?
Cytiva leads on documented platform breadth across perfusion, multicolumn chromatography and connected process control globally. Sartorius competes through Pionic modules that join chromatography and filtration with orchestration for intensified downstream workflows.
Which suppliers document qualification and site certifications?
Repligen publicly lists ISO 9001:2015 registrations for facilities in the United States, Europe and Taiwan. Its quality center also provides regulatory support files for filtration systems and pre-packed chromatography columns.
Which companies provide upstream and process-control technologies?
Repligen combines process analytics with filtration and chromatography technologies across connected production and scale-up workflows. Eppendorf provides bioprocess reactors and control systems for upstream development with qualification and application support.
Which suppliers serve North America, Europe and Asia?
Thermo Fisher directly supports Asian projects through design centers in India, South Korea and Singapore. Repligen supports North America, Europe and Asia through manufacturing and service operations across those regions.
Representative Company Overview
| Company | Positioning | Verified market-relevant capabilities |
|---|---|---|
| Cytiva | Global | Perfusion, multicolumn chromatography and Figurate SCADA integration. |
| Sartorius AG | Global | Pionic chromatography and filtration modules for intensified continuous processes. |
| Thermo Fisher Scientific Inc. | Global | DynaDrive bioreactors, single-use processing and regional design centers. |
| Merck KGaA | Global | BioContinuum processing, Amsphere Protein A resins and filtration technologies. |
| Repligen Corporation | North America, Europe and Asia | Filtration, chromatography and process analytics across connected bioprocess workflows. |
| Eppendorf SE | Global | Bioprocess reactors, control systems and qualification services for upstream development. |
| Getinge AB | Global | Life-science process systems and global service support for regulated production facilities. |
| FUJIFILM Biotechnologies | United States and Europe | MaruX integrated continuous manufacturing and biologics production services. |
Research Methodology
The companies illustrate how continuous bioprocessing competition is structured and do not form a ranking. Inclusion requires current evidence of perfusion, purification, process analytics or integrated manufacturing capability for regulated bioprocessing. Site certifications and quality records apply to the named facility or legal entity instead of every business within a wider corporate group.
